These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23567040)

  • 1. Photochemical internalization (PCI) of immunotoxins targeting CD133 is specific and highly potent at femtomolar levels in cells with cancer stem cell properties.
    Bostad M; Berg K; Høgset A; Skarpen E; Stenmark H; Selbo PK
    J Control Release; 2013 Jun; 168(3):317-26. PubMed ID: 23567040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Light-controlled endosomal escape of the novel CD133-targeting immunotoxin AC133-saporin by photochemical internalization - A minimally invasive cancer stem cell-targeting strategy.
    Bostad M; Olsen CE; Peng Q; Berg K; Høgset A; Selbo PK
    J Control Release; 2015 May; 206():37-48. PubMed ID: 25758331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photochemical internalization of CD133-targeting immunotoxins efficiently depletes sarcoma cells with stem-like properties and reduces tumorigenicity.
    Stratford EW; Bostad M; Castro R; Skarpen E; Berg K; Høgset A; Myklebost O; Selbo PK
    Biochim Biophys Acta; 2013 Aug; 1830(8):4235-43. PubMed ID: 23643966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Light-triggered, efficient cytosolic release of IM7-saporin targeting the putative cancer stem cell marker CD44 by photochemical internalization.
    Bostad M; Kausberg M; Weyergang A; Olsen CE; Berg K; Høgset A; Selbo PK
    Mol Pharm; 2014 Aug; 11(8):2764-76. PubMed ID: 24960585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photochemical internalisation, a minimally invasive strategy for light-controlled endosomal escape of cancer stem cell-targeting therapeutics.
    Selbo PK; Bostad M; Olsen CE; Edwards VT; Høgset A; Weyergang A; Berg K
    Photochem Photobiol Sci; 2015 Aug; 14(8):1433-50. PubMed ID: 25805311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-FU resistant EMT-like pancreatic cancer cells are hypersensitive to photochemical internalization of the novel endoglin-targeting immunotoxin CD105-saporin.
    Lund K; Olsen CE; Wong JJW; Olsen PA; Solberg NT; Høgset A; Krauss S; Selbo PK
    J Exp Clin Cancer Res; 2017 Dec; 36(1):187. PubMed ID: 29258566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting cancer stem cells with an 131I-labeled anti-AC133 monoclonal antibody in human colorectal cancer xenografts.
    Lang J; Lan X; Liu Y; Jin X; Wu T; Sun X; Wen Q; An R
    Nucl Med Biol; 2015 May; 42(5):505-512. PubMed ID: 25669587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photochemical activation of the recombinant HER2-targeted fusion toxin MH3-B1/rGel; Impact of HER2 expression on treatment outcome.
    Bull-Hansen B; Cao Y; Berg K; Skarpen E; Rosenblum MG; Weyergang A
    J Control Release; 2014 May; 182():58-66. PubMed ID: 24637464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel EpCAM-targeting monoclonal antibody 3-17I linked to saporin is highly cytotoxic after photochemical internalization in breast, pancreas and colon cancer cell lines.
    Lund K; Bostad M; Skarpen E; Braunagel M; Kiprijanov S; Krauss S; Duncan A; Høgset A; Selbo PK
    MAbs; 2014; 6(4):1038-50. PubMed ID: 24525727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basic studies on radioimmunotargeting of CD133-positive HCT116 cancer stem cells.
    Jin ZH; Sogawa C; Furukawa T; Saito Y; Aung W; Fujibayashi Y; Saga T
    Mol Imaging; 2012; 11(6):445-50. PubMed ID: 23084245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine-induced killer (CIK) cells bound with anti-CD3/anti-CD133 bispecific antibodies target CD133(high) cancer stem cells in vitro and in vivo.
    Huang J; Li C; Wang Y; Lv H; Guo Y; Dai H; Wicha MS; Chang AE; Li Q
    Clin Immunol; 2013 Oct; 149(1):156-68. PubMed ID: 23994769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photochemical internalization (PCI) of HER2-targeted toxins: synergy is dependent on the treatment sequence.
    Berstad MB; Weyergang A; Berg K
    Biochim Biophys Acta; 2012 Dec; 1820(12):1849-58. PubMed ID: 22981913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The CD133 polyclonal antibody generation and cancer stem cells identification].
    Tian JL; Cai PL; Xia XQ; Li FH; Wang DH; Chen MN
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 May; 42(3):422-6. PubMed ID: 21827013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photochemical internalisation: a novel drug delivery system.
    Selbo PK; Høgset A; Prasmickaite L; Berg K
    Tumour Biol; 2002; 23(2):103-12. PubMed ID: 12065848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disulfonated tetraphenyl chlorin (TPCS2a), a novel photosensitizer developed for clinical utilization of photochemical internalization.
    Berg K; Nordstrand S; Selbo PK; Tran DT; Angell-Petersen E; Høgset A
    Photochem Photobiol Sci; 2011 Oct; 10(10):1637-51. PubMed ID: 21773635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photochemical internalization (PCI): a technology for drug delivery.
    Berg K; Weyergang A; Prasmickaite L; Bonsted A; Høgset A; Strand MT; Wagner E; Selbo PK
    Methods Mol Biol; 2010; 635():133-45. PubMed ID: 20552345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two novel monoclonal antibodies against human CD133-2: distinct epitopes and agonist activity to enhance growth of CD133 expression cells in vitro.
    Wang J; Li F; Zhang G; Chen Y; Hu Y; Chen X; Lu B; Zhang X
    Hybridoma (Larchmt); 2010 Jun; 29(3):241-9. PubMed ID: 20569000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted delivery and enhanced cytotoxicity of cetuximab-saporin by photochemical internalization in EGFR-positive cancer cells.
    Yip WL; Weyergang A; Berg K; Tønnesen HH; Selbo PK
    Mol Pharm; 2007; 4(2):241-51. PubMed ID: 17263556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo documentation of photochemical internalization, a novel approach to site specific cancer therapy.
    Selbo PK; Sivam G; Fodstad O; Sandvig K; Berg K
    Int J Cancer; 2001 Jun; 92(5):761-6. PubMed ID: 11340584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression.
    Skubitz AP; Taras EP; Boylan KL; Waldron NN; Oh S; Panoskaltsis-Mortari A; Vallera DA
    Gynecol Oncol; 2013 Sep; 130(3):579-87. PubMed ID: 23721800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.